Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda - Top-Institutions - MDSpire

Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda

New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included

  • April 9, 2026

  • 2 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)
    National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI)

    Bethesda, MD

    Key Differentiators

    • Hematology
    • Gene Therapy
    • Clinical Research
    • Health Economics

  • #2

    Boston Children's Hospital - Center for Sickle Cell Disease
    Boston Children's Hospital - Center for Sickle Cell Disease

    Boston, MA

    Key Differentiators

    • Pediatric Hematology
    • Gene Therapy
    • Clinical Trials

  • #3

    University of California, Los Angeles (UCLA) - Broad Stem Cell Research Center
    University of California, Los Angeles (UCLA) - Broad Stem Cell Research Center

    Los Angeles, CA

    Key Differentiators

    • Gene Therapy
    • Stem Cell Research
    • Hematology

  • #4

    University of Oxford - Nuffield Department of Medicine
    University of Oxford - Nuffield Department of Medicine

    Oxford, Oxfordshire

    Key Differentiators

    • Global Health
    • Health Economics
    • Hematology

  • #5

    Makerere University College of Health Sciences
    Makerere University College of Health Sciences

    Kampala, Central Region

    Key Differentiators

    • Hematology
    • Global Health
    • Clinical Research

Original Source(s)

Gene Therapy for Sickle Cell Could Be Cost-Effective in Uganda

  • April 9, 2026

Related Content

Effective Treatment of Hemophagocytic Lymphohistiocytosis Linked to Scrub Typhus Using Doxycycline and Immunomodulatory Therapy: A Case Study

Digital Twins for Rare Diseases

AI-driven models address data gaps in rare disease research and diagnostics

  • April 20, 2026

  • 5 min
Emerging Antimicrobial Resistance and the Prevalence of Gram-Negative Bloodstream Infections in Pediatric Acute Myeloid Leukemia Patients Undergoing Induction Chemotherapy at Children’s Cancer Hospital Egypt 57357